Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | hydrastine hydrochloride | 197834 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | hydrastine hydrochloride | 197834 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | hydrastine hydrochloride | 197834 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | hydrastine hydrochloride | 197834 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | hydrastine hydrochloride | 197834 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | hydrastine hydrochloride | 197834 | drug-path |
Gap junction | R-HSA-190861 | map04540 | laudanosine | 15548 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | laudanosine | 15548 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | laudanosine | 15548 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | laudanosine | 15548 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | laudanosine | 15548 | drug-path |
mTOR signaling pathway | R-HSA-165662 | map04150 | laudanosine | 15548 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | laudanosine | 15548 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | thioridazine | 5452 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | thioridazine | 5452 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | thioridazine | 5452 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | thioridazine | 5452 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | thioridazine | 5452 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | thioridazine | 5452 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | thioridazine | 5452 | drug-path |